Clinical Trials Logo

Post-Traumatic Headache clinical trials

View clinical trials related to Post-Traumatic Headache.

Filter by:

NCT ID: NCT05754931 Completed - Clinical trials for Cervicogenic Headache

Deep Neck Flexors Training Versus Muscle Energy Technique on Cervicogenic Headache

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

Aim of this study is to compare the effects of deep neck flexors stretching versus muscles energy technique on pain, cervical range of motion, sleep disturbance and cervical spine posture in patients with Cervicogenic headache and interpret which technique is better among both.A randomized control trial that will include total 28 participants.The first group will receive deep neck flexors stretching along with conventional therapy and 2nd group will receive muscles energy technique along with conventional therapy.Data collected will be analyzed through SPSS 25.

NCT ID: NCT05697445 Not yet recruiting - Clinical trials for Cervicogenic Headache

Combined Effect Of Cranial And Cervical Mobilization In Patients With CGH

Start date: February 2023
Phase: N/A
Study type: Interventional

- The purposes of this study are: - To investigate the combined effect of cranial and cervical mobilization in patient with cervicogenic headache and there effect on : 1. Perceptive neck pain intensity 2. Perceptive headache intensity 3. pain by pressure 4. frequency of headache episodes 5. duration of headache episodes 6. Medications uptakes

NCT ID: NCT05692232 Completed - Clinical trials for Cervicogenic Headache

The Efficacy of Manual Therapy and Pressure Biofeedback Guided Strength Training on Pain and Functional Limitations

Start date: February 20, 2022
Phase: N/A
Study type: Interventional

Cervicogenic headache (CGH) is a widespread illness that results in excruciating pain and a sizable functional handicap. Deep cervical flexor muscle (DCFM) strength and endurance were also worse in CGH patients. This study aimed to determine the efficacy of manual therapy and pressure biofeedback-guided DCFM strength training on pain intensity and functional limitations in individuals with CGH.

NCT ID: NCT05669885 Recruiting - Clinical trials for Post-Traumatic Headache

Hypersensitivity to Phosphodiesterase 5 Inhibition in Post-Traumatic Headache

Start date: January 2, 2023
Phase: N/A
Study type: Interventional

To investigate whether sildenafil (phosphodiesterase 5 inhibitor) induces migraine-like headache in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

NCT ID: NCT05658627 Not yet recruiting - Clinical trials for Cervicogenic Headache

Hamstring Active Release Technique in Cervicogenic Headache

Start date: April 2023
Phase: N/A
Study type: Interventional

It has been suggested that the suboccipital muscles are a causative factor in both cervicogenic neck pain and headache. Hamstrings and sub-occipital muscles are connected by a neural system and sub-occipital muscles pass through the dura Mater. Increased tension and shortening of the hamstring's muscles can cause neck and shoulder pain. In addition, when the muscles around the neck are tensed, the muscles in the limbs are also tensed, so that if the tone of the hamstring muscles is decreased, SLR test score increased, and the tone of the sub-occipital muscles is reduced. Active release technique is found to have an effect on hamstring flexibility.

NCT ID: NCT05635656 Active, not recruiting - Clinical trials for Post-Concussion Syndrome

Digital Solutions for Concussion

DiSCo
Start date: November 25, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to develop new digital solutions for patients with prolonged postconcussion symptoms, and investigate its usability, feasibility, and safety. The digital solutions consist of a 1) symptom mapping and clinical decision support system, and 2) a research-based system for home-based biofeedback treatment.

NCT ID: NCT05620719 Recruiting - Clinical trials for Posttraumatic Headache

Multisite Advancement of Research on Chronic Posttraumatic Headache

Start date: August 24, 2023
Phase: N/A
Study type: Interventional

Posttraumatic headache (PTH) is a common and highly disabling consequence of traumatic brain injury (TBI) in U.S. military service members and veterans. Cognitive Behavioral Therapy for PTH has been shown to significantly improve disability outcomes in veterans with persistent PTH when delivered in-person. Telemedicine platforms can dramatically increase access to evidence-based care. However, whether CBT for PTH retains its effectiveness when delivered through a telemedicine platform has yet to be established. The purpose of this 3-arm randomized clinical trial is to compare Clinic-based Cognitive-Behavioral Therapy (CCBT) to Telemedicine-based Cognitive Behavioral Therapy (TCBT) and to treatment as usual (TAU) in 525 service members and veterans with chronic posttraumatic headaches (PTH) at 3 VA medical centers and 4 military treatment facilities across the U.S. Participants will be assessed for headache-related disability, headache experience, and psychiatric comorbidities across multiple time points.

NCT ID: NCT05617365 Recruiting - Clinical trials for Cervicogenic Headache

Treating Chronic Cervicogenic Head and Neck Pain

CGH
Start date: September 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The primary aim is to test the combined effectiveness of OMT and targeted head exercise (THE) to achieve a significant decrease in headache measures of frequency, intensity, and duration in a Treatment group when compared to a Control group whose members receive only standard medical care. A parallel, 2-arm, longitudinal, randomized controlled trial (RCT) will focus upon female patients (18 to 75 years of age) who have been diagnosed with chronic cervicogenic headache (CeH) based upon a differential diagnosis that includes classification according to the International Headache Society Classification IHSD 3rd Edition, reproduction of referred headache resulting from manual pressure over the upper cervical regions, and objective MRI findings. It is estimated that a sample size of 30 will provide sufficient statistical power (79%) to detect an intervention effect that corresponds to a clinically meaningful recovery (60%). CeH is classified as a secondary headache disorder because the headache pain is a consequence of injury to, or disease of, the bony and/or soft tissues of the upper cervical spine. It has been reported that some patients diagnosed with CeH demonstrate atrophy and/or fatty infiltration (FI) of the RCPm muscles on MRI. FI and/or a reduction in the cross-sectional area (CSA) of active muscle would not be expected to be the direct cause of chronic headache, but either or both could prevent muscles from generating normal physiologic levels of force. It has been shown that there is a functional connection between the pain sensitive dura mater and RCPm muscles and it is known that mechanical stretching of the dura mater results in referred headache. While FI and/or a reduction in the CSA of active muscle would not be expected to be the direct cause of chronic headache, it is known that muscle pathology will result in functional deficits. It is proposed that pathology in RCPm muscles will compromise the normal functional relationship between the RCPm and the dura mater and result in referred head and neck pain. It is predicted that at the end of the study, the Treatment group will show a significant decrease in headache measures that will be accompanied by a significant increase in CSA and a significant decrease in FI on MRI, and restoration of a normal head posture that will not be seen in the Control group. The proposed study is unique in that we are proposing both a mechanism and a source for some instances of CeH. By testing the effectiveness of specific interventions to address a specific pathology within a specific headache population, and by restricting the study cohort to female subjects presenting with CeH, this study will increase the ability to detect a significant change in the outcomes by increasing the power of the statistical analysis.

NCT ID: NCT05595993 Recruiting - Clinical trials for Post-Traumatic Headache

Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache

Start date: October 25, 2022
Phase: N/A
Study type: Interventional

To investigate whether cilostazol (phosphodiesterase 3 inhibitor) induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

NCT ID: NCT05582616 Completed - Clinical trials for Cervicogenic Headache

The Safety and Feasibility of tDCS Combined With Conservative Treatment for Cervicogenic Headaches

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

Annually, up to 150,000 individuals are affected by cervicogenic headaches (CGH) in Canada with many of these cases being chronic. Current treatments for CGH are limited in efficacy and durability - indicating a dire need for novel interventions in this population. Transcranial direct current stimulation (tDCS) and physiotherapy have a high degree of safety and have been studied as interventions for many other chronic pain conditions and headache disorders. We propose to study the feasibility and safety of tDCS alongside physiotherapy for CGH further in a randomized sham controlled trial.